Navigation Links
A drug in vogue to deccelerate the course of Alzheimer's

Alzheimer’s disease continues to fuel research, as the incidence is likely to increase in the future. A new drug has been developed to slow the course of Alzheimer's disease. There is a special chemical called glutamate, which is one of the brain’s messenger and this chemical//is regulated by a drug called Memantine. Learning and memory are the fields, which are enabled by the chemical glutamate. This happens when glutamate is in its normal concentration. Its concentration can increase or decrease according to the level of Alzheimer's disease.

Available treatments for Alzheimer's that have proven effective at treating mild to moderate stages of the disease are aimed at a different chemical system in the brain, the cholinergic system. Memantine has been approved for use in Germany for more than 10 years.

The Food and Drug Administration is reviewing its safety and efficacy for possible U.S. sale of this drug. Approval could happen by this fall. Findings from a randomized, double-blind study of the drug in 252 patients were published in the April 3 New England Journal of Medicine.

Patients who took Memantine seemed to decline about half as much during the six-month trial as would ordinarily be expected, said Barry Reisberg, MD, professor of psychiatry at New York University School of Medicine, who led the study. Another issue that must be teased out is whether antioxidants in a pill are as beneficial as those in food, noted Paula Bickford, PhD, professor of neurosurgery at the University of South Florida, Tampa.
'"/>




Page: 1

Related medicine news :

1. Sun screen in vogue: for fashion and for health!
2. Postpone intercourse after childbirth
3. Satisfied Sexual Intercourse for Impotence men with Penile Prosthesis
4. Schools set to offer Japanese language course
5. A New Study Discredits The Myth Of Sexual Intercourse Late In Pregnancy Speeds Labour & Delivery
6. Indias Law on Homosexuality Needs Recourse - Hampers HIV Prevention
7. Timing of First Intercourse is Vital
8. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
9. Decrease in testosterone levels lead to Alzheimers
10. Smokers are prone to Alzheimers
11. Over-The-Counter Drugs May Prevent Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: